FULGENT GENETICS INC (FLGT:NASDAQ)
$18.14 -0.56 (-2.9947%)
Analysed FULGENT GENETICS INC (FLGT:NASDAQ) News Sources
Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting
22-04-2026
yahoo.com
iRhythm Holdings, Inc. (IRTC) Reports Q1 Loss, Tops Revenue Estimates
30-04-2026
yahoo.com
Fulgent Reports First Quarter 2026 Financial Results
01-05-2026
yahoo.com
Fulgent Genetics, Inc. (FLGT) Reports Q1 Loss, Beats Revenue Estimates
01-05-2026
yahoo.com
Fulgent Genetics Q1 Earnings Call Highlights
01-05-2026
marketbeat.com
Fulgent Genetics, Inc. Q1 2026 Earnings Call Summary
01-05-2026
moby.co
Fulgent Genetics Inc (FLGT) Q1 2026 Earnings Call Highlights: Navigating Challenges with ...
02-05-2026
yahoo.com
Foundation Medicine to Launch FoundationOne®PGx, a Pharmacogenetic Offering, Through Expanded Partnership with Fulgent Genetics
04-05-2026
yahoo.com
Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting
21-05-2026
yahoo.com
Fulgent Presents Updated FID-007 Data at ASCO 2026
01-06-2026
yahoo.com
What is the current price of FULGENT GENETICS INC (FLGT:NASDAQ)?
The current price of FULGENT GENETICS INC (FLGT:NASDAQ) is $18.14.
FULGENT GENETICS INC (FLGT:NASDAQ) absolute price change since previous trading day?
The absolute price change of FULGENT GENETICS INC (FLGT:NASDAQ) since the previous trading day is $-0.56.
FULGENT GENETICS INC (FLGT:NASDAQ) percentage price change since previous trading day?
The percentage price change of FULGENT GENETICS INC (FLGT:NASDAQ) since the previous trading day is -2.9947%.
What is the most recent average sentiment score for FULGENT GENETICS INC (FLGT:NASDAQ)?
The most recent average sentiment score for FULGENT GENETICS INC (FLGT:NASDAQ) is 53 out of 100.
What is the most recent average sentiment for FULGENT GENETICS INC (FLGT:NASDAQ)?
The most recent sentiment for FULGENT GENETICS INC (FLGT:NASDAQ) is .
SEC-8K** Filing Available For FULGENT GENETICS INC (FLGT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.